Work

Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial

Year: 2023

Type: article

Source: Journal of Infection

DOI: 10.1016/j.jinf.2023.06.022

Authors: Christian Taucher, Rajeka Lazarus, Hanna Dellago, Gabriele Maurer, Petronela Weisova, Irena Corbic-Ramljak, Katrin Dubischar, Anders Lilja, Susanne Eder-Lingelbach, Romana Hochreiter, Juan Carlos Jaramillo, Helga Junker, Michael Krammer, Petra Pusic, Benedicte Querton, Julian Larcher-Senn, Markus Hoffmann, Stefan Pöhlmann, Adam Finn

Institutions: Valneva (Austria), University Hospitals Bristol and Weston NHS Foundation Trust, German Primate Center, University of Göttingen, University of Bristol

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institute for Health and Care Research, Department of Health and Social Care

OpenAlex ID: W4382930554

FWCI: 3.274

Cites: 43

Cited by: 17

Related to: 10